13G Filing: Deerfield Management Reveals 5% Stake in Newly-Public Editas Medicine, Inc. (EDIT)

Page 11 of 13

Page 11 of 13 SEC Filing

 
Exhibit List
 
Exhibit A.  Joint Filing Agreement.
 
Exhibit B.  Item 8 Statement.
 
Exhibit C.  Power of Attorney (1).
 
(1) Power of Attorney previously filed as Exhibit 24 to a Form 3 with regard to Editas Medicine, Inc. filed with the Securities and Exchange Commission on February 2, 2016 by Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Management Company, L.P., Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P., Deerfield PDI Financing, L.P., Deerfield PDI Financing II, L.P., Deerfield Private Design Fund II, L.P., Deerfield Private Design International II, L.P., Deerfield International Master Fund, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Mgmt HIF, L.P., Breaking Stick Holdings, LLC, Deerfield Private Design Fund III, L.P. and James E. Flynn.
 

Follow Editas Medicine Inc.

Page 11 of 13